FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α
FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α
复制标题
FoxO4 通过 ERK 介导的 HNF4α 下调抑制 HBV 核心启动子活性。
DOI:
10.1016/j.antiviral.2019.104568
复制
发表时间:
2019-10-01
影响因子:
7.6
通讯作者:
Gao, Bo
中科院分区:
文献类型:
--
作者:
Li, Lijie;Li, Yuqi;Gao, Bo
Hepatitis B virus (HBV) infection remains a global health problem, causing nearly one million deaths annually. Forkhead box O (FoxO) transcription factors play important roles in modulating diverse physiological processes. Recent studies show that FoxOs are involved in antiviral responses. In present investigation, we found that HBV induced significant down-regulation of FoxO4 protein, while had little effect on the expression of FoxO1 and FoxO3. Further study showed that FoxO4 displayed inhibitory effect on HBV transcription and replication both in vitro and in vivo. Mechanistically, it was found that FoxO4 exerted its anti-HBV activity by targeting HBV core promoter. Further, FoxO4 was revealed to inhibit HBV core promoter activity via downregulating hepatocyte nuclear factor-4 alpha (HNF4 alpha), and ERK signaling was required for FoxO4-mediated suppression of HNF4 alpha and HBV core promoter activity. Together, these data indicated that FoxO4 displayed anti-HBV activity by suppressing HNF4 alpha expression via activation of ERK pathway, and targeting FoxO4 might present as a novel therapeutic strategy against HBV infection.